Webinar: The growing utilization of copay accumulator programs

By Dale Hanna; Corey Ford, MHA |

Insights and strategies for manufacturers to consider in light of this new accumulator model.


Over the past four years, commercial health plans and pharmacy benefit managers have devised copay accumulator programs, which exclude the use of manufacturer-sponsored commercial copay assistance from a patient’s accrual of out-of-pocket (OOP) expenses throughout a plan benefit year. As the use of copay accumulators continues against pharmacy benefit drugs, commercial plans may explore new models targeting medical benefit products.
 
With large health plans pursuing accumulator models targeting medical benefit products, manufacturers offering copay assistance for those products will need to incorporate accumulator mitigation strategies into their program design.
 
View our on-demand webinar to learn:

  •  Copay accumulator and maximizer trends
  • Operational solutions
  • Impact on patients and copay programs
  • Future landscape
  • Manufacturer strategies for consideration

Listen to Corey Ford, Director, Reimbursement & Policy Insights for Xcenda and Dale Hanna, Director, Product Management for Lash Group, as they provide insights and strategies for manufacturers to consider in light of this new accumulator model. 


About the Authors

Dale Hanna

Product Director, Adherence Services
Lash Group

Dale Hanna leads the product strategy for Lash Group Adherence Services, specializing in clinical and patient engagement programs. He works with clients and key stakeholders across the business to deliver effective patient-centered support programs.

Mr. Hanna holds a bachelor's degree in Biology from High Point University. 

View Bio
Corey Ford

Corey Ford, MHA

Director, Reimbursement & Policy Insights
Xcenda
View Bio